Mon.Jul 24, 2023

article thumbnail

News Roundup: July 17 to July 23

Drug Topics

Your weekly roundup of the latest news from Drug Topics®.

247
247
article thumbnail

With the neuro tide rising, could a breakthrough for Parkinson’s be next?

PharmaVoice

Amid a wave of neuro R&D, scientists are taking an Alzheimer’s-like approach to developing the first disease-modifying treatments for Parkinson’s.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Handle With Care: Dispensing Controlled Substances in the Pharmacy

Drug Topics

Filling a prescription for a controlled substance requires more oversight than the average prescription.

article thumbnail

Responding to declining pharmacy reimbursement with an alternative channel strategy

PharmaVoice

Commercial teams need to accept the reality of declining pharmacy reimbursement as an important variable in their go-to-market equation.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Exercise, Training May Improve Global Cognition in Older Patients With Mild Dementia

Pharmacy Times

Exercise alone or vitamin D supplementation did not clinically improve cognition in adults with mild cognitive impairment.

123
123
article thumbnail

Consolidated hospitals leading to larger premiums and out-of-pocket spending, report finds

Fierce Healthcare

As hospitals acquire ambulatory care centers, consumers are more likely to be forced to pay outpatient facility fees for routine care traditionally covered by physician offices at lower costs. | Customers are being surprised with larger medical bills to cover a hospital's operational expenses, and hospital consolidation is major driving factor, a Georgetown University report uncovered.

More Trending

article thumbnail

Implementing Cloud-Based Plant Management Software: Data Security Considerations for Pharma Companies

ISPE

Implementing Cloud-Based Plant Management Software: Data Security Considerations for Pharma Companies Trudy Patterson Mon, 07/24/2023 - 11:13 iSpeak Blog iSpeak Implementing Cloud-Based Plant Management Software: Data Security Considerations for Pharma Companies Andreas Eschbach 24 July 2023 Cloud-based systems for plant process management (PPM) deliver significant benefits in terms of access, convenience and easy management.

article thumbnail

Multiple Studies Reinforce Biktarvy as Treatment for Diverse Range of Patients With HIV

Pharmacy Times

The once-daily therapeutic agent is effective for pediatric patients and pregnant women with HIV.

123
123
article thumbnail

Labor shortages, Medicaid redeterminations: These are the headwinds facing payers, providers this year

Fierce Healthcare

While payers are facing headwinds going into the latter part of this year, the ongoing financial impacts of healthcare's labor shortage will be felt in the hospital sector far longer, according to | While payers are facing headwinds going into the latter part of this year, the ongoing financial impacts of healthcare's labor shortage will be felt in the hospital sector far longer, according to a new report from analysts at Moody's Investors Service.

article thumbnail

The Rise of AI in Pharmacy Practice Presents Benefits and Challenges

Pharmacy Times

Pharmacists must carefully consider safety concerns and patient privacy.

123
123
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Roche to co-develop hypertension RNAi therapeutic

European Pharmaceutical Review

Roche and Alnylam Pharmaceuticals have agreed to jointly develop and commercialise zilebesiran, an RNAi therapeutic as a treatment for hypertension. Under the partnership, Alnylam will receive an upfront payment of $310 million from Roche and is eligible to receive development, regulatory and commercial milestones. Zilebesiran is an investigational, subcutaneously administered RNAi therapeutic targeting angiotensinogen (AGT).

98
article thumbnail

Single injection of zilebesiran for hypertension provides 24-week sustained reduction in blood pressure

Hospital Pharmacy Europe

A single subcutaneous injection of zilebesiran, which inhibits hepatic angiotensinogen synthesis, maintained a reduced 24-hour ambulatory blood pressure for 24 weeks, an international research team has found. If approved, the drug paves the way for a more convenient means of managing hypertension, which is normally treated with oral antihypertensive agents.

article thumbnail

STAT+: Lawsuit says Cigna illegally denies claims in bulk, sticking patients with unexpected bills

STAT

A new lawsuit accuses Cigna of using an algorithm to automatically deny claims in bulk instead of individually reviewing each case, putting patients on the hook for bills the health insurer otherwise would have paid. The complaint filed Monday in the Northern District of California says Cigna uses a system called PXDX to identify discrepancies between diagnoses and the tests and services it covers for those ailments.

article thumbnail

Is it safe to mix Benadryl and melatonin to sleep?

The Checkup by Singlecare

It’s 2 a.m. and you’re lying in bed, wide awake. Despite tucking in hours ago, you have yet to fall asleep. Or, perhaps you drifted off for a few hours, but now peaceful slumber eludes you. Trouble falling asleep—or staying asleep—is a fairly common problem. Insomnia affects 10% to 30% of the adult population, according to studies , mostly impacting women, older adults, and people with medical or mental health issues.

Dosage 98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Opinion: Drug pricing and the ‘impossible trinity’ for patients

STAT

You don’t have to be an economist to understand the law of demand: The higher the price, the less likely a customer is to buy a product. This, of course, limits how much companies can charge. The law of demand applies to pharmaceuticals, but with one big difference. It’s not always the customer who decides that the price is too high. Often, it’s the insurer.

article thumbnail

Verrica gains FDA approval for Verrica’s YCANTH to treat molluscum

Pharmaceutical Technology

Verrica has received approval from the US FDA for its YCANTH to treat molluscum in adult and paediatric patients aged two years and above.

FDA 98
article thumbnail

Drug Store News, Chain Drug Review and The Emerson Group collaborate to honor NACDS’ 90th anniversary

Drug Store News

Registration is now open for the Dec. 13 event in New York City.

98
article thumbnail

Dozens of studies paint private equity's provider purchases in a negative light

Fierce Healthcare

A body of published academic data suggest that private equity ownership of healthcare providers frequently comes with higher costs and reduced quality, according to a systematic literature review p | Evidence of private equity ownership's detrimental impact on healthcare providers is "robust enough" to warrant greater scrutiny and possibly new regulations, researchers wrote in a recent 55-study literature review.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Conagra Brands adds new products across frozen, grocery and snacks

Drug Store News

The new launches span across single-serve meals, multi-serve meals, snacks and appetizers from many of its brands.

98
article thumbnail

STAT+: Key House panel proposes lowering out-of-pocket drug costs in Medicare

STAT

WASHINGTON — A key House committee announced its own plans to increase health care transparency and reduce some health care costs for patients on Monday, according to bill text obtained by STAT. The House Ways & Means Committee package includes a new provision that would ensure that patients in the Medicare program pay for medicines they pick up at the pharmacy counter based on the discounted price that insurers negotiate with drugmakers, instead of higher sticker prices, starting in

article thumbnail

Joint Commission to revise another 200+ standards next month

Fierce Healthcare

The Joint Commission unveiled the second tranche of its planned accreditation standards reduction, which will become effective Aug. 27. | The second tranche of an ongoing standards review primarily focused on accreditation requirements for non-hospital programs.

article thumbnail

STAT+: Roche’s $3 billion Alnylam deal shows drug firms are interested in long-acting heart drugs

STAT

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease. If things go well, Roche could pay Alnylam up to $2.8 billion in total. Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug

article thumbnail

LexisNexis Reed Tech Expands Portfolio, Now Offers eCTD Services

Pharmaceutical Commerce

Solution includes assistance with submitting regulatory submissions.

98
article thumbnail

Walgreens taps Monica Reed as VP of Walgreens Health Centers strategy and operations

Drug Store News

Reed will be responsible for leading Walgreens Health Corners.

98
article thumbnail

Eversana, Amazon Web Service Partner to Accelerate Artificial Intelligence Across Life Sciences Industry

PharmExec

Collaboration aims to help pharmaceuticals drive efficiencies and business value.

98
article thumbnail

STAT+: Gene therapy eyedrops restored a boy’s sight. Similar treatments could help millions

STAT

MIAMI — Dr. Alfonso Sabater pulled up two photos of Antonio Vento Carvajal’s eyes. One showed cloudy scars covering both eyeballs. The other, taken after months of gene therapy  given through eyedrops, revealed no scarring on either eye. Antonio, who’s been legally blind for much of his 14 years, can see again. The teen was born with dystrophic epidermolysis bullosa, a rare genetic condition that causes blisters all over his body and in his eyes.

98
article thumbnail

Designing for behaviour change: The key to success in digital health

pharmaphorum

Designing for behaviour change: The key to success in digital health Mike.

97
article thumbnail

STAT+: Roche’s $3 billion Alnylam deal shows drug firms are interested in long-acting heart drugs

STAT

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease. If things go well, Roche could pay Alnylam up to $2.8 billion in total. Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug

article thumbnail

Deborah Lippmann’s Glam, Cozy collections prep nails for fall

Drug Store News

The nail polish brand is prepping nails for the upcoming fall season with a new collection.

97
article thumbnail

Opinion: How do doctors’ personal political affiliations affect how they care for their patients?

STAT

This essay is adapted from “ Random Acts of Medicine: The Hidden Forces That Sway Doctors, Impact Patients, and Shape Our Health ,” out now from Doubleday. “H oney, I forgot to duck,” Ronald Reagan said to his wife as he was wheeled to the operating room of George Washington University Hospital on March 30, 1981. He had just been shot and was bleeding into his left chest.

article thumbnail

Virtual health can reduce industry’s carbon footprint, says Blue Shield of California

Fierce Healthcare

Virtual healthcare holds the key to not only increasing patient satisf | Virtual healthcare can not only improve outcomes and the patient experience, but it can also help reduce healthcare’s carbon footprint, according to Blue Shield of California.

95
article thumbnail

Watch: In a children’s hospital gardens, families find sanctuary

STAT

Boston Children’s Hospital is located in the heart of the city’s bustling Longwood medical area. But within this dense urban landscape, there are pockets of solace for patients, their families and hospital employees. The hospital has 10 dedicated garden spaces on site. Dotted with statuary of snails, foxes, and frogs, these facilities are specially designed to accommodate the complicated needs of their patients.

article thumbnail

Amazon adds benefits to FamilyFlex program

Drug Store News

Amazon is adding new benefits to its FamilyFlex program that provides flexible scheduling and resources for employees and their family members.

95